Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Alvimopan (Entereg) Pre-Op/Post-Op [3041300020] General Alvimopan (ENTEREG) Orders Patient Criteria for Alvimopan (ENTEREG) use: 1. Planned surgery is for partial large or small bowel resection with primary anastomosis. 2. Patient has NOT taken therapeutic doses of opioids for more than seven (7) consecutive days immediately prior to taking Alvimopan (ENTEREG). 3. Patient does NOT have severe hepatic disorders. (Child-Pugh Class C) 4. Patient does NOT have end stage renal disease (ESRD). 5. Patient MUST receive a dose pre-operatively in order to qualify for post-operative ENTEREG therapy. Only to be used for patients receiving parenteral / oral opioids post-op. Patients receiving ONLY epidural opioids post-op are unlikely to benefit from Alvimopan (ENTEREG). Residents/ Interns: Discuss appropriateness of alvimopan (ENTEREG) with the attending surgeon before ordering. Post-op alvimopan should only be placed after the procedure is completed and it is verified that criteria are still met. Duration of therapy should not exceed 14 doses POST-op. [ ] PRE-Procedure alvimopan (ENTEREG) Must be given 30 minutes to 5 hours prior to surgery. [ ] alvimopan (ENTEREG) capsule x 1 Pre-procedure [ ] POST-Procedure alvimopan (ENTEREG) Fast Track Protocol- Patient WITH NG [ ] Discontinue NG [ ] Diet 12 mg, Oral, 60 min pre-procedure, For 1 Doses, Pre-Procedure [] Give in Pre-op with sip of water. [] Do NOT open capsule. [] Must be given 30 minutes to 5 hours prior to surgery. Is planned/performed surgery for large or small bowel resection with primary anastomosis? Has patient taken therapeutic doses of opioids for more than 7 consecutive days immediately preop? Does patient have severe hepatic disorders (Child-Pugh Class C)? Does patient have end stage renal disease (ESRD)? "And" Linked Panel Routine, Once For 1 Occurrences Specify: (if present) prior to first post-op dose of Alvimopan Post-Procedure Diet effective now, Starting S Regular or Special Diet?: Special Special Diet: Liquid Liquid Diet: Clear Liquid Fluid Restriction / 24h: Fluid Restriction total / 24h: Optional Preferences / Modifiers: Post-Procedure Page 1 of 3 [ ] Progress to target diet [ ] Diet instructions to nursing [ ] Ambulate patient [ ] alvimopan (ENTEREG) capsule [ ] POST-Procedure alvimopan (ENTEREG) Fast Track Protocol- Patient WITHOUT NG [ ] Diet [ ] Progress to target diet [ ] Diet instructions to nursing [ ] Ambulate patient Routine, 3 times daily with meals, Starting S+1 at 5:00 AM Regular or Special Diet?: Special Special Diet: Liquid Liquid Diet: Full Liquid Fluid Restriction / 24h: Fluid Restriction total / 24h: Optional Preferences / Modifiers: As tolerated, Post-Procedure Routine, Until discontinued, Starting S+2 at 5:00 AM Specify: Encourage solid food beginning POD #2 Post-Procedure Routine, Daily, Starting S+1 Specify: Encourage ambulation beginning POD #1 Post-Procedure 12 mg, Oral, 2 times daily, S+1 at 9:00 AM, For 14 Doses, Post-Procedure [] Discontinue drug upon first post-operative bowel movement and tolerating fluids orally [] NURSE to notify pharmacy to discontinue; PHARMACIST to discontinue Alvimopan per protocol [] FOR INPATIENT USE ONLY. DO NOT CONTINUE OR PRESCRIBE UPON DISCHARGE Is planned/performed surgery for large or small bowel resection with primary anastomosis? Did patient receive alvimopan (ENTEREG) dose preop? "And" Linked Panel Diet effective now, Starting S Regular or Special Diet?: Special Special Diet: Liquid Liquid Diet: Clear Liquid Fluid Restriction / 24h: Fluid Restriction total / 24h: Optional Preferences / Modifiers: Post-Procedure Routine, 3 times daily with meals, Starting S+1 at 5:00 AM Regular or Special Diet?: Special Special Diet: Liquid Liquid Diet: Full Liquid Fluid Restriction / 24h: Fluid Restriction total / 24h: Optional Preferences / Modifiers: As tolerated, Post-Procedure Routine, Until discontinued, Starting S+2 at 5:00 AM Specify: Encourage solid food beginning POD #2 Post-Procedure Routine, Daily, Starting S+1 Specify: Encourage ambulation beginning POD #1 Post-Procedure Page 2 of 3 [ ] alvimopan (ENTEREG) capsule 12 mg, Oral, 2 times daily, S at 6:00 PM, For 14 Doses, Post-Procedure [] Discontinue drug upon first post-operative bowel movement and tolerating fluids orally [] NURSE to notify pharmacy to discontinue; PHARMACIST to discontinue Alvimopan per protocol [] FOR INPATIENT USE ONLY. DO NOT CONTINUE OR PRESCRIBE UPON DISCHARGE Is planned/performed surgery for large or small bowel resection with primary anastomosis? Did patient receive alvimopan (ENTEREG) dose preop? Page 3 of 3